Antituberculosis activities of clofazimine and its new analogs B4154 and B4157

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 633-636

  Reddy, Venkata M ^a   Nadadhur, Geeta ^a   Daneluzzi, Donna ^a   O'Sullivan, J F ^b   Gangadharam, Pattisapu R J ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c M/C 790 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B 4154; B 4157; CLOFAZIMINE; CLOFAZIMINE DERIVATIVE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FEMALE; MACROPHAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0029995215     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.633     Document Type: Article

References (12)

1. Barry, V. C. 1964. The development of chemotherapeutic agent for tuberculosis, p. 46-64. In V. C. Barry (ed.), Chemotherapy of tuberculosis. Butterworths, London.
2. Barry, V. C., J. G. Belton, M. L. Conalty, J. M. Denneny, D. W. Edward, J. F. O'Sullivan, and D. Twomey. 1957. A new series of phenazines (riminocompounds) with high antituberculosis activity. Nature (London) 179:1013-1015.
3. Barry, V. C., and M. L. Conalty. 1965. The antimycobacterial activity of B663. Lepr Rev. 36:1-7.
4. Conalty, M. L. 1964 Methods of preclinical evaluation of antituberculosis drugs. p. 150-174. In V C. Barry (ed.), Chemotherapy of tuberculosis Butterworths, London.
5. Gangadharam, P. R. J., D. Ashtekar, and J. F. O'Sullivan. 1992. In vitro, in vivo, and intracellular chemotherapeutic activity of B746, a clofazimine analogue against Mycobacterium avium complex. Tubercle Lung Dis 73:192-199.
6. Gangadharam, P. R. J., V. K. Perumal, N. R. Podapati, L. Kesavalu, and M. Iseman. 1988. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobucterium intracellulare complex infections in beige mice. Antimicrob. Agents Chemother. 32:1400-1403
7. Jagannath, C., M. V. Reddy, S. Kailasam, J. F. O'Sullivan, and P. R. J. Gangadharam. 1995. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. Am. J. Respir Care. Care Med 51:1083-1086.
8. Lee, C., and L. Heifets. 1987. Determination of minimal inhibitory concentrations of anti-tuberculosis drugs by radiometric and conventional methods Am Rev. Respir. Dis. 136:349-352.
9. Lindholm Levy, P. J., and L. B. Heifets. 1988. Clofazimme and other rimino compounds minimal inhibitory and minimal bactericidal concentrations at different pHs of Mycobacterium avium complex. Tubeicle 69:179-186.
10. Reddy, M. V., and P. R. J. Gangadharam. Unpublished data
11. Reddy, M. V., S. Srinivasan, B. Andersen, and P. R. J. Gangadharam. 1994. Rapid assessment of mycobacterial growth inside macrophages and mice, using radiometric (BACTEC) method. Tubercle Lung Dis. 75:127-131.
12. Saito, H., and K. Sato. 1989. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium mtracellulare infection in mice, Tubercle 70:201-205.